IL121659A - Method for determining CPSA in a blood sample - Google Patents

Method for determining CPSA in a blood sample

Info

Publication number
IL121659A
IL121659A IL12165997A IL12165997A IL121659A IL 121659 A IL121659 A IL 121659A IL 12165997 A IL12165997 A IL 12165997A IL 12165997 A IL12165997 A IL 12165997A IL 121659 A IL121659 A IL 121659A
Authority
IL
Israel
Prior art keywords
fpsa
cpsa
antibody
specific
binding
Prior art date
Application number
IL12165997A
Other languages
English (en)
Other versions
IL121659A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27419236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL121659(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/903,750 external-priority patent/US5840501A/en
Application filed by Bayer Ag filed Critical Bayer Ag
Priority to IL13023097A priority Critical patent/IL130230A/en
Publication of IL121659A0 publication Critical patent/IL121659A0/xx
Publication of IL121659A publication Critical patent/IL121659A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Cephalosporin Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL12165997A 1996-10-25 1997-08-29 Method for determining CPSA in a blood sample IL121659A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL13023097A IL130230A (en) 1996-10-25 1997-08-29 Method for the detection of prostate cancer from blood levels of prostate specific antigen

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73838396A 1996-10-25 1996-10-25
US83496997A 1997-04-07 1997-04-07
US08/903,750 US5840501A (en) 1996-10-25 1997-07-31 Determination of cPSA

Publications (2)

Publication Number Publication Date
IL121659A0 IL121659A0 (en) 1998-02-22
IL121659A true IL121659A (en) 2000-07-16

Family

ID=27419236

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12165997A IL121659A (en) 1996-10-25 1997-08-29 Method for determining CPSA in a blood sample

Country Status (14)

Country Link
US (2) US5928878A (de)
EP (1) EP0838680B1 (de)
JP (1) JP4274330B2 (de)
AT (1) ATE267399T1 (de)
AU (1) AU746345B2 (de)
CA (1) CA2214488C (de)
CZ (1) CZ295854B6 (de)
DE (1) DE69729156T2 (de)
DK (1) DK0838680T3 (de)
ES (1) ES2221006T3 (de)
HU (1) HU221350B1 (de)
IL (1) IL121659A (de)
NO (1) NO974534L (de)
PT (1) PT838680E (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19641560A1 (de) * 1996-10-09 1998-04-16 Boehringer Mannheim Gmbh Monoklonale Antikörper gegen einen Komplex aus humanem ACT und einer Serinprotease
CA2243033A1 (en) * 1997-07-31 1999-01-31 Bayer Corporation Determination of psa-act
WO1999033878A1 (en) * 1997-12-25 1999-07-08 Japan Tobacco Inc. Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
GB9827845D0 (en) * 1998-12-17 1999-02-10 Scolab S A Immunoassay or proteins
CA2311512A1 (en) * 1999-07-24 2001-01-24 Bayer Corporation Reflex method for the detection of prostate cancer
JP3536731B2 (ja) * 1999-07-28 2004-06-14 富士レビオ株式会社 ＨＩＶ−１ｐ２４抗原の免疫測定方法及び試薬
US6569684B2 (en) 2000-01-06 2003-05-27 University Of Central Florida Method of identifying and treating invasive carcinomas
US6379550B1 (en) 2000-07-24 2002-04-30 Health Research, Inc. Method for detecting PSA and its molecular forms using thiophilic gel
DE60107022T2 (de) 2000-07-24 2005-11-24 Health Research Inc. Verfahren zur Detektion von Prostata-spezifischem Membran-Antigen in Serum
ATE420201T1 (de) * 2000-08-07 2009-01-15 Univ Vanderbilt Nachweis der cox-2 aktivität und von anandamid- metaboliten
CA2422856C (en) * 2000-09-25 2012-02-07 Abbott Laboratories Methods and kits for decreasing interferences of assay samples containing plasma or serum in specific binding assays by using a large polycation
US6764825B1 (en) * 2000-10-13 2004-07-20 Tang J. Wang Methods and device for detecting prostate specific antigen (PSA)
US7226749B2 (en) * 2000-12-05 2007-06-05 Zahradnik Richard J Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
US6838264B2 (en) * 2000-12-05 2005-01-04 Immutopics, Inc. Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (PTH) 1-84
AU2003242815A1 (en) * 2002-03-13 2003-09-22 Biomerieux Method for the characterisation of circulating tumour cells stemming from solid cancers
US7666981B1 (en) 2002-05-10 2010-02-23 University Of Central Florida Research Foundation, Inc. Inhibitors of prostasin
US20040018580A1 (en) * 2002-05-10 2004-01-29 Chai Karl X. Synthetic substrates for prostasin
US7314709B2 (en) * 2002-08-06 2008-01-01 Vanderbilt University Compositions and methods for detecting and quantifying COX-2 activity by lipoamino acid metabolism
EP1507147A1 (de) * 2003-08-12 2005-02-16 Erasmus University Medical Center Rotterdam Verfahren zum Nachweiss von niedrigem Gehalt an Fusionsprotein
ATE412181T1 (de) * 2004-01-28 2008-11-15 Turun Yliopisto Verbessertes verfahren zur diagnose des akuten koronarsyndroms
US8012694B2 (en) 2006-09-14 2011-09-06 Immutopics, Inc. Assay for the detection of phosphorylated PTH
EP2107377A1 (de) * 2008-04-04 2009-10-07 BRAHMS Aktiengesellschaft Pro-Endothelin-1-Spiegel für die Risikobestimmung von tachyarrhthmischen Ereignissen
JP5415520B2 (ja) * 2008-04-09 2014-02-12 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 最大酸素消費量低下の予測のためのプロ−エンドセリン−１
US8658166B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US8632971B2 (en) 2011-11-08 2014-01-21 Caldera Health Limited Methods and materials for determining the efficacy of prostate cancer therapies
US20130116131A1 (en) 2011-11-08 2013-05-09 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
US8658164B2 (en) 2011-11-08 2014-02-25 Caldera Health Limited Methods and materials for the diagnosis of prostate cancers
JP6604081B2 (ja) * 2014-08-13 2019-11-13 東ソー株式会社 Ｎ型糖鎖が付加している膵臓リボヌクレアーゼ１の測定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0690203B2 (ja) * 1985-08-23 1994-11-14 中外製薬株式会社 前立腺特異抗原とα▲下１▼−アンチトリプシン複合体の定量方法
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
DE4322342A1 (de) * 1993-07-05 1995-02-09 Gif Ges Fuer Immunologische Fo Verfahren für die Differentialdiagnostik des Prostata-Karzinoms
EP0635575A1 (de) * 1993-07-22 1995-01-25 Wallac Oy Monoklonale Antikörper gegen Epitope in freiem uber nicht in Alpha-1-antichymotrypsin komplexiertem Prostata spezifisches Antigen
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5698402A (en) * 1995-02-23 1997-12-16 Dianon Systems, Inc. Methods for diagnosing benign prostatic hyperplasia
US5710007A (en) * 1995-09-29 1998-01-20 Luderer; Albert A. Methods for diagnosing prostatic adenocarcinoma

Also Published As

Publication number Publication date
CA2214488A1 (en) 1998-04-25
CZ295854B6 (cs) 2005-11-16
JPH10177027A (ja) 1998-06-30
HUP9701717A2 (hu) 1998-05-28
IL121659A0 (en) 1998-02-22
US6107049A (en) 2000-08-22
DE69729156T2 (de) 2005-05-25
AU3926797A (en) 1998-04-30
PT838680E (pt) 2004-08-31
DE69729156D1 (de) 2004-06-24
HUP9701717A3 (en) 2000-04-28
US5928878A (en) 1999-07-27
DK0838680T3 (da) 2004-09-27
ES2221006T3 (es) 2004-12-16
NO974534D0 (no) 1997-10-01
NO974534L (no) 1998-04-27
ATE267399T1 (de) 2004-06-15
CA2214488C (en) 2007-06-19
CZ335797A3 (cs) 1998-05-13
HU9701717D0 (en) 1997-12-29
HU221350B1 (en) 2002-09-28
AU746345B2 (en) 2002-04-18
EP0838680B1 (de) 2004-05-19
EP0838680A1 (de) 1998-04-29
JP4274330B2 (ja) 2009-06-03

Similar Documents

Publication Publication Date Title
IL121659A (en) Method for determining CPSA in a blood sample
CA2384579A1 (en) Early cancer tumor marker
IL143892A0 (en) Kidney disease detection and treatment
SI1078264T1 (sl) Tumorski oznacevalci
WO2000034787A1 (en) Cancer detection method and reagents
US5994085A (en) Methods and devices for detecting non-complexed prostate specific antigen
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
DE3780480D1 (de) Test fuer menschlichen brustkrebs.
CA2361000A1 (en) Urinary trypsin inhibitor to diagnose aids
NZ335535A (en) Immunohistochemical assay for carcinoma proliferative status by detecting presence of NGAL protein
AU2001285820A1 (en) Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
ATE378601T1 (de) Diagnostischer test für menschlisches matrix gla- protein und seine verwendung als biomarker
DE69811157D1 (de) Immunoassay zur Bestimmung von PSA-ACT
JP5048207B2 (ja) 敗血症状態の発症および存在を決定するための装置及び方法
CA2409208A1 (en) Method for examining wt1-related disease
WO1997039351A1 (en) Novel methods for the prediction and early detection of prostatic adenocarcinoma
CA2311702A1 (en) A method for detection of carcinoembryonic antigens having a modified sugar chain structure
DK1200826T3 (da) Immunoassay og testanordning med integreret reference
Christofidis Scientific background of the project
Christofidis Scientific background of the project [Radioimmunometric assay for Prostate Specific Antigen (PSA) measurement]
Kruk Detection of cancer by elevated levels of BCL-2
EP1072890A2 (de) Verfahren zum Nachweis von Prostatakrebs

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees